Company Overview of BioVascular, Inc.
BioVascular, Inc., a biotechnology company, develops and commercializes drugs and devices for the control of intimal hyperplasia associated with vascular procedures and control of risk factors in cardiovascular morbidity and mortality applications. Its products include Saratin, a polypeptide produced by recombinant means in yeast and is designed to apply during surgery to the endovascular surface; and a release formulation for cardiovascular risk reduction. The company is based in San Diego, California.
12230 El Camino Real
San Diego, CA 92130
Key Executives for BioVascular, Inc.
Similar Private Companies By Industry
|Grifols Inc.||United States|
|Tissue Engineering, Inc.||United States|
|MIGENIX Corp.||United States|
|Centrexion Corp||United States|
|Zosano Pharma, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- New York City, NY | BloombergPosted: Apr 14
- South San Francisco, CA | GenentechPosted: Apr 16
- Delaware | DuPontPosted: Apr 11
- Miami, FL | Sterling Life SciencesPosted: Apr 13
Sponsored Financial Commentaries
To contact BioVascular, Inc., please visit www.biovascularinc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.